Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00759096 · ClinicalTrials.gov registry record · NA
Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL
A NA study of Visual Acuity, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00759096: Completed NA study of Visual Acuity, sponsored by Alcon Research.
NCT00759096 is a NA study of Visual Acuity that has completed, run by Alcon Research. The registered enrollment target is 30 participants, below the 139-participant average among 20 other Visual Acuity trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00759096, a NA study of Visual Acuity, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess uniocular and binocular unaided distance, intermediate, and near VA; contrast sensitivity, accommodation amplitude, stereopsis, glare testing, ocular aberrations and the clinical satisfaction assessment after bilateral implant of the Restor IOL.
Primary Outcome
Near uncorrected visual acuity(UCVA) measured in logMAR. LogMAR is the logarithm of the minimum angle of resolution and is used to measure visual acuity.
Conditions Studied
Interventions
- DEVICE RESTOR IOL Model SA60D3
Study Locations (1)
Texas
- Alcon Call Center - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-07 |
| Phase | NA |
What the finished NCT00759096 record still lists
NCT00759096 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 139-participant average among 20 other Visual Acuity trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 1 intervention - of which RESTOR IOL Model SA60D3 is the first listed.
NCT00759096 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00759096 about?
NCT00759096 is a clinical study titled "Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL". The purpose of this study is to assess uniocular and binocular unaided distance, intermediate, and near VA; contrast sensitivity, accommodation amplitude, stereopsis, glare testing, ocular aberrations and the clinical satisfaction assessment after bilateral implant of the Restor IOL.
What is the current status of trial NCT00759096?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2007-05. Estimated completion is 2008-07.
What conditions does trial NCT00759096 study?
This clinical trial studies the following conditions: Visual Acuity.
What interventions are being tested in trial NCT00759096?
The interventions under investigation include: RESTOR IOL Model SA60D3 (DEVICE).
Who is sponsoring clinical trial NCT00759096?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00759096 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Visual Acuity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00759096's enrollment target sits among peer trials
30 20th of 20 the lowest of 20 other Visual Acuity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Visual Acuity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Effect of Scatter on Visual Performance
RECRUITING · NA
-
Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2
COMPLETED · NA
-
Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses
COMPLETED · NA
-
Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
COMPLETED · NA
-
Clinical Evaluation of Approved Contact Lenses
COMPLETED · NA
-
Clinical Evaluation of Manufacturing Processes for a Reusable Multifocal Optical Design in a Presbyopic Population
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia